09/10/2026
Two psychiatrists are now authorized to prescribe pharmaceutical-grade M**A to selected adults with PTSD who haven't responded to other treatments, following Australia's lead.
It's restricted access, not legalization. But it's another step toward treating M**A as medicine instead of a crime.
New Zealand has authorized two psychiatrists to prescribe pharmaceutical-grade M**A to selected adults with PTSD, creating a tightly controlled treatment pathway while the drug remains officially unapproved.